Home › Companies › ARCTURUS THERAPEUTICS HOLDINGS INC. › 2023-2024

ARCTURUS THERAPEUTICS HOLDINGS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ARCTURUS THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed 2024-06-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 15Reported items
  • 208Asset managers
  • 2,731Fund votes
  • 2024-06-14Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ARCTURUS THERAPEUTICS HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ARCTURUS THERAPEUTICS HOLDINGS INC.

These tallies are ARCTURUS THERAPEUTICS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ARCTURUS THERAPEUTICS HOLDINGS INC. — official shareholder meeting results, meeting held 2024-06-14
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
The proposal was approved. Proposal No. 3 19,875,9301,069,59258,600 --2,305,768 Majority: yes
The proposal was approved. Proposal No. 4 23,267,44930,12012,321 ---- Majority: yes

Source: ARCTURUS THERAPEUTICS HOLDINGS INC., Form 8-K, filed with the SEC on 2024-06-14 — read the filing on EDGAR.

How asset managers voted at the ARCTURUS THERAPEUTICS HOLDINGS INC. 2023-2024 meeting

Each item below shows how the 208 asset managers that disclosed a ARCTURUS THERAPEUTICS HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ARCTURUS THERAPEUTICS HOLDINGS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 3 of the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 199 asset managers below cast 94% of the shares they voted on this item FOR (22,651,186 for, 1,437,688 against).

FOR: 22,651,186 (94.0%)AGAINST: 1,437,688 (6.0%)
Largest asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes9,390,7440 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,350,7640 00For
Fidelity476,476735,453 00Against
BlackRock1,144,4839,999 00For
Nikko Asset Management Americas, Inc.1,117,1190 00For
State Street830,541141 00For
Dimensional639,6000 00For
Putnam549,4020 00For
Woodline Partners LP485,3960 00For
Wellington447,3430 00For
JUPITER ASSET MANAGEMENT LTD419,1250 00For
Charles Schwab382,0660 00For
American Century0353,552 00Against
GEODE CAPITAL MANAGEMENT, LLC313,1480 00For
Granahan Investment Management, LLC297,0420 00For
Portolan Capital Management, LLC268,2640 00For
Hartford177,3130 00For
Nikko Asset Management Co., Ltd.159,9800 00For
UBS0149,064 00Against
Northern Trust143,4351,086 00For
Royce131,7180 00For
Jackson National127,4370 00For
Neuberger Berman126,0470 00For
Nuveen123,8120 00For

Showing the 25 largest of 199 asset managers. See all 199 in the interactive database.

2. To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

77% fund support · no official result

FOR 76%AGAINST 22%

The 75 asset managers below cast 77% of the shares they voted on this item FOR (9,012,587 for, 2,637,873 against).

FOR: 9,012,587 (76.5%)AGAINST: 2,637,873 (22.4%)ABSTAIN: 131,718 (1.1%)
Largest asset managers voting on “To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan"” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity13,699829,828 00Against
Dimensional0531,598 00Against
BlackRock489,1660 00For
State Street210239,764 00Against
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century0175,141 00Against
Royce00 129,8360Abstain
Jackson National0127,437 00Against
Direxion Shares ETF Trust0115,941 00Against
TIAA092,520 00Against
Equitable39,81025,410 00For
Harbor Funds II60,8800 00For
Goldman Sachs059,416 00Against
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS042,547 00Against
Neuberger Berman41,3480 00For
John Hancock27,2809,081 00For
Lincoln Financial035,359 00Against
Nushares ETF Trust030,159 00Against
JPMorgan029,819 00Against

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

3. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 97%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,455,683 for, 0 against).

FOR: 11,455,683 (97.2%)ABSTAIN: 326,495 (2.8%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street4460 239,5280Abstain
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial15,5590 19,8000Abstain
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

4. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 97%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,386,748 for, 0 against).

FOR: 11,386,748 (96.6%)ABSTAIN: 395,430 (3.4%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 367,0510For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9260 480For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

5. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.7%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,753,799 for, 0 against).

FOR: 11,753,799 (99.8%)ABSTAIN: 28,379 (0.2%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9260 480For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

6. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 97%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,415,105 for, 0 against).

FOR: 11,415,105 (96.9%)ABSTAIN: 367,073 (3.1%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 367,0510For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 220For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

7. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,782,156 for, 0 against).

FOR: 11,782,156 (100.0%)ABSTAIN: 22 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 220For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

8. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 97%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,389,695 for, 0 against).

FOR: 11,389,695 (96.7%)ABSTAIN: 392,483 (3.3%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 367,0510For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 220For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable39,8100 25,4100For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

9. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,782,156 for, 0 against).

FOR: 11,782,156 (100.0%)ABSTAIN: 22 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 220For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

10. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 74 asset managers below cast 100% of the shares they voted on this item FOR (11,782,178 for, 0 against).

FOR: 11,782,178 (100.0%)
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accoun” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9740 00For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

11. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 62 asset managers below cast 100% of the shares they voted on this item FOR (6,533,367 for, 0 against).

FOR: 6,533,367 (100.0%)ABSTAIN: 279 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 220For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
MFS42,5470 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For
Victory Capital29,1810 00For
ProShares29,0480 00For
BRIDGEWAY FUNDS INC28,1600 00For
Northern Trust27,6830 00For
UBS22,3870 00For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

12. Elect Andrew H. Sassine

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 99%

The 14 asset managers below cast 100% of the shares they voted on this item FOR (5,181,222 for, 0 against).

FOR: 5,181,222 (98.7%)ABSTAIN: 67,310 (1.3%)
Largest asset managers voting on “Elect Andrew H. Sassine” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
Charles Schwab191,0330 00For
Hartford177,3130 00For
Northwestern Mutual43,1370 00For
Neuberger Berman00 41,3480Abstain
Putnam26,7620 00For
MML SERIES INVESTMENT FUND26,1500 00For
New York Life13,7510 00For
Global X00 13,0490Abstain
SEI00 12,0840Abstain
MassMutual7,2940 00For
NEW COVENANT FUNDS00 4830Abstain
Principal4100 00For
Nationwide00 3460Abstain

13. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

94% fund support · no official result

FOR 94%

The 4 asset managers below cast 94% of the shares they voted on this item FOR (1,215,948 for, 83,166 against).

FOR: 1,215,948 (93.6%)AGAINST: 83,166 (6.4%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.930,0000 00For
JPMorgan285,9480 00For
NORDEA INVESTMENT MANAGEMENT AB057,325 00Against
Desjardins Global Asset Management Inc.025,841 00Against

14. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (23,071 for, 0 against).

FOR: 23,071 (100.0%)
Largest asset managers voting on “14A Executive Compensation” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Investment Managers Series Trust II22,7170 00For
Granite Investment Partners, LLC3540 00For

15. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31,2023

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (712 for, 0 against).

FOR: 712 (100.0%)
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Orion Porfolio Solutions, LLC3560 00For
Orion Portfolio Solutions, LLC3560 00For

Largest ARCTURUS THERAPEUTICS HOLDINGS INC. shareholders voting in 2023-2024

Ranked by the number of ARCTURUS THERAPEUTICS HOLDINGS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 26,917,000 shares outstanding at the time of that meeting.

Top ARCTURUS THERAPEUTICS HOLDINGS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Federated Hermes 34.89%
2ARK ETF Trust 6.48%
3Vanguard 5.02%
4Fidelity 4.50%
5BlackRock 4.29%
6Nikko Asset Management Americas, Inc. 4.15%
7State Street 3.09%
8Dimensional 2.38%
9Putnam 2.04%
10Woodline Partners LP 1.80%

Reported ARCTURUS THERAPEUTICS HOLDINGS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ARCTURUS THERAPEUTICS HOLDINGS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 9.53% 13F
State Street 7.28% 13F
Vanguard Group 7.01% 13F
Dimensional Fund Advisors 4.10% 13F
Morgan Stanley 2.62% 13F
Geode Capital 2.04% 13F
Point72 1.25% 13F
Wellington Management 1.06% 13F
Northern Trust 0.88% 13F
JPMorgan Chase 0.76% 13F

Percentages above are of 26,917,000 shares outstanding, as reported by ARCTURUS THERAPEUTICS HOLDINGS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ARCTURUS THERAPEUTICS HOLDINGS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ARCTURUS THERAPEUTICS HOLDINGS INC.'s shareholder meeting held 2024-06-14, in the 2023-2024 proxy season, 208 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,731 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ARCTURUS THERAPEUTICS HOLDINGS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — the reporting funds cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

ARCTURUS THERAPEUTICS HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.